Less than a third of heavily advertised drugs have 'high therapeutic value': study
Television ads for drugs are filled with glowing images of people living their best lives, all thanks to that new med they've been prescribed.
Jan 19, 2023
1
73
Television ads for drugs are filled with glowing images of people living their best lives, all thanks to that new med they've been prescribed.
Jan 19, 2023
1
73
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth. ...
Dec 19, 2022
0
69
A large team of researchers at Emulate Inc., working with colleagues from several institutions in the U.S., has found that human liver-chips are showing promise as a predictive toxicology tool. In their paper published in ...
Nearly half of Americans with Medicare now get their health insurance coverage through a private company that takes part in the federal government's Medicare Advantage program.
Dec 7, 2022
0
64
A short, simple and safe drug treatment developed at Tel Aviv University reduced the risk of the spread of cancer metastases after surgery to remove the primary tumor—according to the first clinical study of its kind conducted ...
Dec 6, 2022
0
155
Scientists from the National University of (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate ...
Dec 5, 2022
0
133
The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.
Nov 29, 2022
0
75
Zooming in on a single disease and studying it intensely is often the most productive route to finding treatments. But there's no easy way to distinguish among people living with any of the primary tauopathies—a group of ...
Nov 24, 2022
0
77
Scientists at Scripps Research have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective.
Nov 3, 2022
0
46
Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner ...
Oct 27, 2022
0
184